Search for: "Watson Laboratories" Results 101 - 120 of 249
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Aug 2012, 9:00 pm by Patent Docs
Watson Laboratories, Inc. 3:12-cv-05228; filed August 20, 2012 in the District Court of New Jersey Infringement of U.S. [read post]
5 Aug 2012, 7:54 pm by Patent Docs
• Defendants: Watson Pharmaceuticals Inc.; Watson Laboratories Inc.; Watson Pharma Inc. [read post]
3 May 2012, 6:07 pm
In 2009, Allergan and its business partners, Endo Pharmaceutical Solutions and Supernus Pharmaceuticals, filed their complaint in Delaware that Watson and its business partners, Florida, Sandoz and Paddock Laboratories, had infringed on Allergan patents involving trospium chloride extended release capsules to treat the symptoms of overactive bladders in humans. [read post]
25 Apr 2012, 9:05 am by FDABlog HPM
  The owners of the three approved ANDAs for generic oral vancomycin—Akorn, Incorporated (“Akorn”), Watson Laboratories, Inc. [read post]
18 Apr 2012, 8:15 pm by Patent Docs
Watson Pharmaceuticals, Inc., et al. 1:12-cv-00321; filed March 30, 2012 in the Middle District of North Carolina • Plaintiffs: Allergan, Inc.; Duke University • Defendants: Watson Pharmaceuticals, Inc.; Watson Laboratories, Inc.; Watson Pharma, Inc. [read post]
10 Apr 2012, 1:15 pm by Tom Lamb
  The Zarah and Vestura oral contraceptives are made by Watson Pharmaceuticals; and Loryna, a generic version of YAZ, and Syeda, a generic version of Yasmin. [read post]
19 Feb 2012, 8:55 pm by Patent Docs
• Defendants: Watson Pharmaceuticals, Inc.; Watson Laboratories Inc. [read post]
4 Dec 2011, 8:52 pm by Patent Docs
• Defendants: Watson Pharmaceuticals, Inc.; Watson Laboratories, Inc.; Watson Laboratories, Inc. [read post]
4 Dec 2011, 9:38 am
It was originally introduced by Berlex Laboratories in Yasmin. [read post]
2 Dec 2011, 10:28 am
Watson Pharmaceuticals and Ranbaxy Laboratories both announced plans to distribute a generic version of atorvastatin containing the same active ingredients under its own brand. [read post]
1 Dec 2011, 2:02 pm by Tom Lamb
(NYSE: WPI) today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration for its Abbreviated New Drug Application for Vestura(TM) (3 mg drospirenone and 0.02 mg ethinyl estradiol), a generic version of Bayer's Yaz(R) oral contraceptive product. [read post]